 |
|
|
|
November 2008 Cover
|
|
In a move that surprised pretty much nobody in the HIV community, the US health department has canceled what would have been a major study of an experimental HIV vaccine known as PAVE-100. The vaccine worked in a very similar way to a vaccine created by Merck, which made global headlines last year when a huge international study found it failed to prevent HIV, and in fact might have increased HIV risk for some people.
Anthony Fauci, the head of the US National Institute of Allergy and Infectious Diseases, said a pared-down version of the PAVE-100 study might still be approved, but that more research must be done to figure out whether the vaccine works before starting widespread testing in humans
from TheBody.com
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
